Targeting transcriptional co-activators in advanced prostate cancer.
a Department of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.|b Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.
Anna C
AC
Groner
a Department of Medical Oncology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.|b Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.
Myles
M
Brown
c Institute of Oncology Research, Oncology Institute of Southern Switzerland , Bellinzona , Switzerland.|d Faculty of Biology and Medicine, Center Hospitalier, Universitaire Vaudois, University of Lausanne , Lausanne , Switzerland.
Jean-Philippe
JP
Theurillat
D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms; D011944:Receptors, Androgen; D014157:Transcription Factors
D011944:Receptors, Androgen; D014157:Transcription Factors
Bromodomain; LXXLL motif; TRIM24; prostate cancer progression; targeting androgen receptor-mediated transcription